Form 4: USANA CSO Exercises RSUs, Sells Shares for Tax

USANA Health Sciences' Chief Scientific Officer, Kathryn Michelle Armstrong, exercised restricted stock units and sold a portion of the resulting common stock to cover tax obligations.

Summary

• Kathryn Michelle Armstrong, Chief Scientific Officer of USANA Health Sciences Inc. (USNA), reported transactions involving company stock.
• On February 27, 2026, Armstrong exercised 4,190 Restricted Stock Units (RSUs), converting them into 4,190 shares of USNA common stock.
• Concurrently, 2,015 shares of common stock were disposed of at a price of $21.52 per share, likely to cover tax liabilities associated with the RSU vesting and exercise.
• Following these transactions, Armstrong directly beneficially owns 2,823 shares of common stock.
• Armstrong also directly beneficially owns 40,592 Restricted Stock Units.
• The Restricted Stock Units vest 25% on the anniversary of February 27, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, reflecting a routine insider transaction related to executive compensation rather than a significant change in company fundamentals or insider sentiment.

Positives

• The exercise of Restricted Stock Units indicates a vesting event, allowing the Chief Scientific Officer to realize value from previously granted equity compensation.

Negatives

• A portion of the acquired common stock (2,015 shares) was sold, reducing the direct common stock holdings, although this is a common practice for tax withholding upon RSU vesting.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that this Form 4 filing represents a routine insider transaction, common for executives receiving equity compensation. The exercise of Restricted Stock Units and subsequent sale of shares for tax purposes is a standard practice in executive compensation plans across various industries, including health and wellness.

Stakeholder Impact

• Shareholders: This is a routine transaction and is unlikely to have a significant impact on the company's share price or long-term value. It provides transparency into executive compensation practices.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

This Form 4 details a routine insider transaction where the Chief Scientific Officer exercised vested Restricted Stock Units and sold a portion of the resulting shares to cover tax liabilities. Such transactions are common and do not typically signal a change in the company's operational performance or the insider's long-term confidence, thus warranting a 'hold' recommendation.

Keywords

USANA Health Sciences, USNA, Form 4, Insider Transaction, Restricted Stock Units, RSU Exercise, Executive Compensation, Chief Scientific Officer, Stock Sale